{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01199",
      "entity_text" : "CD31",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0828" ],
      "Organ" : [ "uberon:UBERON:0000105" ]
    }
  },
  "verbose_text" : "To evaluate the associations of MYPT1 / CD31 combined expression with various clinicopathological parameters of PCa, all 234 PCa patients were divided into MYPT1-low / CD31-high (n = 61), MYPT1-high / CD31-low (n = 71), MYPT1-low / CD31-low (n = 50) and MYPT1-high / CD31-high (n = 50) groups by setting cut-off value at the median MYPT1 or CD31 expression level.",
  "reading_complete" : "2020-07-28T13:11:12Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T13:08:02Z",
  "trigger" : "level",
  "evidence" : [ "CD31 expression level" ],
  "pmc_id" : "6302349",
  "score" : 0
}